The National Institute of Allergy and Infectious Diseases recently awarded $17 million to Grace Aldrovandi, MD, CM, principal investigator at The Saban Research Institute of Children’s Hospital Los Angeles, according to a press release. The grant will fund research as part of the International Maternal Pediatric Adolescent AIDS Clinical Trials, or IMPAACT, network.
“HIV infection is a global public health issue, with children, adolescents and women being particularly vulnerable,” Aldrovandi said in the release. “Our work on optimizing the prevention, diagnosis and treatment of HIV infection in these populations will benefit nations, communities and families throughout the world.”
Aldrovandi, who is also professor of pediatrics, pathology, molecular microbiology and immunology at the Keck School of Medicine, University of Southern California, will oversee more than 50 IMPAACT laboratories located in the United States, Asia, Africa and India. The trials conducted at these laboratories will focus on, among other efforts, curing HIV, preventing mother-to-child transmission, optimizing antiretroviral therapies and evaluating and improving treatments and diagnostics for tuberculosis.
“Childhood stands out as the single best time to maximize our human potential, Brent Polk, MD, director of The Saban Research Institute, said in the release. “Dr. Aldrovandi’s innovative work and worldwide collaborations to reduce the effects of HIV infection in pregnant women, infants, children and adolescents will improve the lives of families directly impacted by HIV and TB. And because their outcomes will be better, our global community will benefit greatly from their talents and contributions to our future.”